[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

Search Results (122)

Search Parameters:
Keywords = GOFs

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
23 pages, 670 KiB  
Article
Distributed Adaptive Optimization Algorithm for High-Order Nonlinear Multi-Agent Stochastic Systems with Lévy Noise
by Hui Yang, Qing Sun and Jiaxin Yuan
Entropy 2024, 26(10), 834; https://doi.org/10.3390/e26100834 - 30 Sep 2024
Viewed by 353
Abstract
An adaptive neural network output-feedback control strategy is proposed in this paper for the distributed optimization problem (DOP) of high-order nonlinear stochastic multi-agent systems (MASs) driven by Lévy noise. On the basis of the penalty-function method, the consensus constraint is removed and the [...] Read more.
An adaptive neural network output-feedback control strategy is proposed in this paper for the distributed optimization problem (DOP) of high-order nonlinear stochastic multi-agent systems (MASs) driven by Lévy noise. On the basis of the penalty-function method, the consensus constraint is removed and the global objective function (GOF) is reconstructed. The stability of the system is analyzed by combining the generalized Itô’s formula with the Lyapunov function method. Moreover, the command filtering mechanism is introduced to solve the “complexity explosion” problem in the process of designing virtual controller, and the filter errors are compensated by introducing compensating signals. The proposed algorithm has been proved that the outputs of all agents converge to the optimal solution of the DOP with bounded errors. The simulation results demonstrate the effectiveness of the proposed approach. Full article
(This article belongs to the Special Issue Information Theory in Control Systems, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>The block diagram of the designed control system.</p>
Full article ">Figure 2
<p>Topology of the communication graph.</p>
Full article ">Figure 3
<p>The system state <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mrow> <mi>i</mi> <mo>,</mo> <mn>1</mn> </mrow> </msub> <mfenced separators="" open="(" close=")"> <mrow> <mi>i</mi> <mo>=</mo> <mn>1</mn> <mo>,</mo> <mo>⋯</mo> <mo>,</mo> <mn>5</mn> </mrow> </mfenced> </mrow> </semantics></math>.</p>
Full article ">Figure 4
<p>The error <math display="inline"><semantics> <mrow> <msub> <mi>s</mi> <mrow> <mi>i</mi> <mo>,</mo> <mn>1</mn> </mrow> </msub> <mfenced separators="" open="(" close=")"> <mrow> <mi>i</mi> <mo>=</mo> <mn>1</mn> <mo>,</mo> <mo>⋯</mo> <mo>,</mo> <mn>5</mn> </mrow> </mfenced> </mrow> </semantics></math>.</p>
Full article ">Figure 5
<p><math display="inline"><semantics> <msub> <mi>x</mi> <mrow> <mn>1</mn> <mo>,</mo> <mn>2</mn> </mrow> </msub> </semantics></math> and its estimation.</p>
Full article ">Figure 6
<p>Control input <math display="inline"><semantics> <msub> <mi>u</mi> <mi>i</mi> </msub> </semantics></math>.</p>
Full article ">Figure 7
<p>The value of the penalty function.</p>
Full article ">Figure 8
<p>The value of the gradient.</p>
Full article ">
13 pages, 4196 KiB  
Article
Performance and Evaluation of Slow-Release Fertilizer Encapsulated by Waterless Synthesized GO Sheets
by Hsuhui Cheng, Yishi He, Yuxing Xian and Xiangying Hao
Coatings 2024, 14(9), 1215; https://doi.org/10.3390/coatings14091215 - 20 Sep 2024
Viewed by 477
Abstract
Slow-release fertilizer was developed by encapsulating NPK compound pellets with graphene oxide (GO) sheets employing a waterless synthesis technique. As-prepared GO sheets were characterized by XRD, Raman, XPS, FTIR, SEM, and EDS. The XRD patterns of the GO sheets indicate that the peak [...] Read more.
Slow-release fertilizer was developed by encapsulating NPK compound pellets with graphene oxide (GO) sheets employing a waterless synthesis technique. As-prepared GO sheets were characterized by XRD, Raman, XPS, FTIR, SEM, and EDS. The XRD patterns of the GO sheets indicate that the peak for the GO is observed at 2θ = 9.3°, and the peak (002) for graphite vanished. Moreover, a higher intensity ratio of the Raman ID/IG of the GO sheets than that of pristine graphite confirms the oxidation of the graphite. The FTIR and XPS analyses provided information on electronic structure, chemical structure, and oxygen-bonding neighbors. The SEM images indicated the GO sheet, whereby its morphology resembles a thin curtain or corrugated shape. The EDS spectrum of coated GO-F pellets revealed the distribution of C, O, N, P, and K elements in the synthesized materials. Afterwards, GO shell formation on fertilizer pellets greatly improved the slow-release characteristics of fertilizer, thus providing plants with their requisite nutrients and reducing environmental pollution. Full article
(This article belongs to the Section Surface Characterization, Deposition and Modification)
Show Figures

Figure 1

Figure 1
<p>Schematic of GO material synthesis.</p>
Full article ">Figure 2
<p>Schematic illustration of preparation of GO-coated composite fertilizer.</p>
Full article ">Figure 3
<p>XRD patterns of GO sheet and graphite.</p>
Full article ">Figure 4
<p>Raman spectra for GO sheet and graphite.</p>
Full article ">Figure 5
<p>FTIR spectra of GO sheet.</p>
Full article ">Figure 6
<p>C 1s (<b>a</b>) and O1s (<b>b</b>) core-level XPS spectra of GO sheet.</p>
Full article ">Figure 7
<p>SEM-EDS analysis of (<b>a</b>) GO Sheet; (<b>b</b>,<b>c</b>) GO-F particle observation of shell section; and (<b>d</b>) EDS spectra of GO-F.</p>
Full article ">Figure 8
<p>The release rate of nutrients vs. time for the GO-F and F pellets (<b>a</b>–<b>c</b>); and (<b>d</b>) photograph of GO-F and F pellets soaking in water.</p>
Full article ">
8 pages, 4266 KiB  
Case Report
Expanding the Spectrum of Autosomal Dominant ATP6V1A-Related Disease: Case Report and Literature Review
by Fabio Sirchia, Ivan Taietti, Myriam Donesana, Francesco Bassanese, Andrea Martina Clemente, Eliana Barbato, Alessandro Orsini, Alessandro Ferretti, Gian Luigi Marseglia, Salvatore Savasta and Thomas Foiadelli
Genes 2024, 15(9), 1219; https://doi.org/10.3390/genes15091219 - 18 Sep 2024
Viewed by 677
Abstract
Background: Developmental and epileptic encephalopathies (DEE) are a group of disorders often linked to de novo mutations, including those in the ATP6V1A gene. These mutations, particularly dominant gain-of-function (GOF) variants, have been associated with a spectrum of phenotypes, ranging from severe DEE and [...] Read more.
Background: Developmental and epileptic encephalopathies (DEE) are a group of disorders often linked to de novo mutations, including those in the ATP6V1A gene. These mutations, particularly dominant gain-of-function (GOF) variants, have been associated with a spectrum of phenotypes, ranging from severe DEE and infantile spasms to milder conditions like autism spectrum disorder and language delays. Methods: We aim to expand ATP6V1A-related disease spectrum by describing a six-year-old boy who presented with a febrile seizure, mild intellectual disability (ID), language delay, acquired microcephaly, and dysmorphic features. Results: Genetic analysis revealed a novel de novo heterozygous pathogenic variant (c.82G>A, p.Val28Met) in the ATP6V1A gene. He did not develop epilepsy, and neuroimaging remained normal over five years of follow-up. Although ATP6V1A mutations have traditionally been linked to severe neurodevelopmental disorders, often with early-onset epilepsy, they may exhibit milder, non-progressive phenotypes, challenging previous assumptions about the severity of ATP6V1A-related conditions. Conclusions: This case expands the known clinical spectrum, illustrating that not all patients with ATP6V1A mutations exhibit severe neurological impairment or epilepsy and underscoring the importance of including this gene in differential diagnoses for developmental delays, especially when febrile seizures or dysmorphic features are present. Broader genotype–phenotype correlations are essential for improving predictive accuracy and guiding clinical management, especially as more cases with mild presentations are identified. Full article
(This article belongs to the Special Issue Genetics and Therapy of Neurodevelopmental Disorders)
Show Figures

Figure 1

Figure 1
<p>Clinical phenotype of the patient showing microcephaly, long face (<span class="html-fig-inline" id="genes-15-01219-i001"><img alt="Genes 15 01219 i001" src="/genes/genes-15-01219/article_deploy/html/images/genes-15-01219-i001.png"/></span>), mild malar hypoplasia (<span class="html-fig-inline" id="genes-15-01219-i002"><img alt="Genes 15 01219 i002" src="/genes/genes-15-01219/article_deploy/html/images/genes-15-01219-i002.png"/></span>), mild hypotelorism (<span class="html-fig-inline" id="genes-15-01219-i003"><img alt="Genes 15 01219 i003" src="/genes/genes-15-01219/article_deploy/html/images/genes-15-01219-i003.png"/></span>), and lifted ears (<b>*</b>) (<b>a</b>), with particular focus on teeth characterized by enamel dysplasia (<span class="html-fig-inline" id="genes-15-01219-i004"><img alt="Genes 15 01219 i004" src="/genes/genes-15-01219/article_deploy/html/images/genes-15-01219-i004.png"/></span>) (<b>b</b>).</p>
Full article ">Figure 2
<p>Standard 19-electrode EEG (20 s/pag—20 µV/mm). (<b>a</b>) first sleep EEG at the age of 5 years. Normal background sleep activity during N2 NREM phase, adequate representation of the physiological spindles, with some superimposed delta waves on the fronto-temporal regions. (<b>b</b>) The last follow-up wake EEG at the age of 11 years. Normal background activity with occipital alfa rhythm at 8 Hz. No sign of slow or epileptiform abnormality.</p>
Full article ">Figure 3
<p>Magnetic Resonance Imaging (MRI) of the reported patient (<b>a</b>) sagittal Fluid Attenuated Inversion Recovery (FLAIR) sequence; (<b>b</b>) axial T1-weighted inversion recovery (IR) sequence. MRI showed no typical alterations of <span class="html-italic">ATP6V1A</span> patients (e.g., hypomyelination and encephalic hypoplasia/atrophy).</p>
Full article ">
12 pages, 4364 KiB  
Article
Modeling Fluid Flow in Ship Systems for Controller Tuning Using an Artificial Neural Network
by Nur Assani, Petar Matić, Danko Kezić and Nikolina Pleić
J. Mar. Sci. Eng. 2024, 12(8), 1318; https://doi.org/10.3390/jmse12081318 - 4 Aug 2024
Viewed by 588
Abstract
Flow processes onboard ships are common in order to transport fluids like oil, gas, and water. These processes are controlled by PID controllers, acting on the regulation valves as actuators. In case of a malfunction or refitting, a PID controller needs to be [...] Read more.
Flow processes onboard ships are common in order to transport fluids like oil, gas, and water. These processes are controlled by PID controllers, acting on the regulation valves as actuators. In case of a malfunction or refitting, a PID controller needs to be re-adjusted for the optimal control of the process. To avoid experimenting on operational real systems, models are convenient alternatives. When real-time information is needed, digital twin (DT) concepts become highly valuable. The aim of this paper is to analyze and determine the optimal NARX model architecture in order to achieve a higher-accuracy model of a ship’s flow process. An artificial neural network (ANN) was used to model the process in MATLAB. The experiments were performed using a multi-start approach to prevent overtraining. To prove the thesis, statistical analysis of the experimental results was performed. Models were evaluated for generalization using mean squared error (MSE), best fit, and goodness of fit (GoF) measures on two independent datasets. The results indicate the correlation between the number of input delays and the performance of the model. A permuted k-fold cross-validation analysis was used to determine the optimal number of voltage and flow delays, thus defining the number of model inputs. Permutations of training, test, and validation datasets were applied to examine bias due to the data arrangement during training. Full article
(This article belongs to the Special Issue Data-Driven Methods for Marine Structures)
Show Figures

Figure 1

Figure 1
<p>Flow control system.</p>
Full article ">Figure 2
<p>Flowchart of the data sampling.</p>
Full article ">Figure 3
<p>Flowchart of the proposed methodology for training the ANN NARX models.</p>
Full article ">Figure 4
<p>Flowchart of the data preparation methodology and training of the ANN NARX models.</p>
Full article ">Figure 5
<p>Flowchart of the ANN NARX models’ testingon two new time–series datasets.</p>
Full article ">Figure 6
<p>Convergence of the MSE during training: (<b>a</b>) using 1st permutation of data; (<b>b</b>) using 2nd permutation of data; (<b>c</b>) using 3rd permutation of data; (<b>d</b>) using 4th permutation of data; (<b>e</b>) using 5th permutation of data; and (<b>f</b>) using 6th permutation of data.</p>
Full article ">Figure 7
<p>Time-response of the best-performing ANN NARX model compared to the previously developed TF model using additional test dataset 1.</p>
Full article ">Figure 8
<p>Response time of the best-performing ANN NARX model compared to the previously developed TF model using additional test dataset 2.</p>
Full article ">Figure 9
<p>Error plot of the best-performing ANN NARX model compared to the target values from test dataset 2.</p>
Full article ">
24 pages, 2918 KiB  
Review
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions
by Marco Cordani, Alessia Garufi, Rossella Benedetti, Marco Tafani, Michele Aventaggiato, Gabriella D’Orazi and Mara Cirone
Biomolecules 2024, 14(6), 649; https://doi.org/10.3390/biom14060649 - 31 May 2024
Viewed by 1358
Abstract
The p53 protein is the master regulator of cellular integrity, primarily due to its tumor-suppressing functions. Approximately half of all human cancers carry mutations in the TP53 gene, which not only abrogate the tumor-suppressive functions but also confer p53 mutant proteins with oncogenic [...] Read more.
The p53 protein is the master regulator of cellular integrity, primarily due to its tumor-suppressing functions. Approximately half of all human cancers carry mutations in the TP53 gene, which not only abrogate the tumor-suppressive functions but also confer p53 mutant proteins with oncogenic potential. The latter is achieved through so-called gain-of-function (GOF) mutations that promote cancer progression, metastasis, and therapy resistance by deregulating transcriptional networks, signaling pathways, metabolism, immune surveillance, and cellular compositions of the microenvironment. Despite recent progress in understanding the complexity of mutp53 in neoplastic development, the exact mechanisms of how mutp53 contributes to cancer development and how they escape proteasomal and lysosomal degradation remain only partially understood. In this review, we address recent findings in the field of oncogenic functions of mutp53 specifically regarding, but not limited to, its implications in metabolic pathways, the secretome of cancer cells, the cancer microenvironment, and the regulating scenarios of the aberrant proteasomal degradation. By analyzing proteasomal and lysosomal protein degradation, as well as its connection with autophagy, we propose new therapeutical approaches that aim to destabilize mutp53 proteins and deactivate its oncogenic functions, thereby providing a fundamental basis for further investigation and rational treatment approaches for TP53-mutated cancers. Full article
(This article belongs to the Special Issue Advances in p53 Research 2024)
Show Figures

Figure 1

Figure 1
<p>Mutant p53’s oncogenic pathways impacting cellular metabolism and invasion. (<b>A</b>) How mutant p53 inhibits the SESN1/AMPK/PGC-1α/UCP2 axis, increasing (↑) ROS levels and cell proliferation while decreasing (↓) autophagy and enhancing (↑) mitochondrial activity, contributing to chemoresistance. (<b>B</b>) The adaptive metabolic responses driven by mutant p53, including stimulation of amino acid biosynthesis and nucleotide biosynthesis pathways, fostering cancer cell invasiveness.</p>
Full article ">Figure 2
<p>Role of mutant p53 in the enhancement of the Warburg effect and its downstream effects on the tumor microenvironment (TME). Mutant p53 augments glucose uptake through GLUT-1 translocation and stimulates glycolytic signaling pathways including RhoA/ROCK and AKT/AMPK, leading to increased pro-tumoral secretome production. The secretome, enriched with extracellular vesicles, exosomes, and oncometabolites, activates cancer-associated fibroblasts (CAFs), promotes extracellular matrix (ECM) remodeling, and induces angiogenesis, thereby facilitating tumor progression and metastasis. Additionally, mutant p53 interacts with HIF-1α to further support the pro-tumoral secretome and enhance tumor growth and metastatic spread.</p>
Full article ">Figure 3
<p>The signaling pathways through which mutant p53 influences tumor invasion. Mutp53 activates STAT3, which is implicated in promoting tumor progression and invasion. Additionally, mutp53 regulates the recycling of EGFR and integrins, integral membrane proteins that are key facilitators of cell migration. Mutp53 also increases Onco-miR production, induces epithelial–mesenchymal transition (EMT) and interacts with SQSTM1/p62, which plays a role in degrading cell-junction-associated proteins, thus enabling cancer cell migration. Collectively, these pathways contribute to enhanced tumor cell invasiveness and the metastatic potential of cancer cells.</p>
Full article ">Figure 4
<p>Schematic representation of mutp53 accumulation following impairment of the proteasome system. MDM2 ubiquitinates (Ub, small green symbols) mutp53 for proteasomal degradation, while heat shock proteins HSP90 and HSP70, along with HSP40, stabilize mutp53, preventing its ubiquitination and degradation. HSP90 inhibits MDM2 activity. The co-chaperone protein CHP further ubiquitinates mutp53, enhancing its degradation. HSP40 directly impairs CHIP activity. TRIM21 directly targets mutp53 for ubiquitination and proteasomal degradation, counteracting its accumulation in tumor cells. Impairment of MDM2, CHIP and TRIM activity leads to increased mutp53 stability.</p>
Full article ">Figure 5
<p>Mutant p53 degradation by autophagy. Activation (↑) of autophagy by different conditions (summarized in the blue rectangle) induces mutp53 degradation (purple small circles) leading to reduction (↓) of GOF; sometimes, degradation of mutp53 reactivates the wild-type function. Inhibition of autophagy by different mechanisms (summarized in the red rectangle) impairs mutp53 degradation.</p>
Full article ">Figure 6
<p>Degradation pathways for mutant p53. (<b>A</b>) Schematic representation of the balance between the different degradative routes and the stabilization/degradation of mutp53. Blocking (↓) of the proteasome upregulates (↑) autophagy while reduction of autophagy activates (↑) chaperone-mediated autophagy (CMA). (<b>B</b>) Activation (↑) of CMA by different conditions (in the blue rectangle), triggers mutp53 binding to both Hsc70 and LAMP-2A, chaperoning mutp53 to the lysosomes for degradation. The potential effect (?) of mutp53 degradation by microautophagy (MI) or chaperone-assisted selective autophagy (CASA) through Hsc70 is also shown.</p>
Full article ">Figure 7
<p>Interaction of mutant p53 with molecular chaperones and co-chaperones that regulate its stability within the cell. Heat shock proteins HSP90 and HSP70, along with co-chaperone HSP40 and BAG family members BAG1, BAG2, and BAG5, are depicted binding to mutp53 to stabilize and prevent its degradation. Mutp53 contributes to increasing the HSP90 expression through the HSF1 transcription factor. On the other hand, HSP70 blocks the MDM2 function and BAG2 and 5 block the CHIP activity. These interactions contribute to increased mutp53 protein stability.</p>
Full article ">Figure 8
<p>Schematic representation of HSPs inactivation/activation. HSPs regulation by small molecules or by post-translational modifications.</p>
Full article ">
12 pages, 1069 KiB  
Article
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
by Amit Mahipal, Michael H. Storandt, Emily A. Teslow, Ellen Jaeger, Melissa C. Stoppler, Zhaohui Jin and Sakti Chakrabarti
Cancers 2024, 16(10), 1823; https://doi.org/10.3390/cancers16101823 - 10 May 2024
Viewed by 1042
Abstract
Background: The predictive and prognostic role of BRAF alterations has been evaluated in colorectal cancer (CRC); however, BRAF alterations have not been fully characterized in non-CRC gastrointestinal (GI) malignancies. In the present study, we report the frequency and spectrum of BRAF alterations among [...] Read more.
Background: The predictive and prognostic role of BRAF alterations has been evaluated in colorectal cancer (CRC); however, BRAF alterations have not been fully characterized in non-CRC gastrointestinal (GI) malignancies. In the present study, we report the frequency and spectrum of BRAF alterations among patients with non-CRC GI malignancies. Methods: Patients with CRC and non-CRC GI malignancies who underwent somatic tumor profiling via a tissue-based or liquid-based assay were included in this study. Gain-of-function BRAF alterations were defined as pathogenic/likely pathogenic somatic short variants (SVs), copy number amplifications ≥8, or fusions (RNA or DNA). Results: Among 51,560 patients with somatic profiling, 40% had CRC and 60% had non-CRC GI malignancies. BRAF GOF alterations were seen more frequently in CRC (8.9%) compared to non-CRC GI malignancies (2.2%) (p < 0.001). Non-CRC GI malignancies with the highest prevalence of BRAF GOF alterations were bile duct cancers (4.1%) and small intestine cancers (4.0%). Among BRAF GOF alterations, class II (28% vs. 6.8%, p < 0.001) and class III (23% vs. 14%, p < 0.001) were more common in non-CRC GI malignancies. Among class II alterations, rates of BRAF amplifications (3.1% vs. 0.3%, p < 0.001) and BRAF fusions (12% vs. 2.2%, p < 0.001) were higher in non-CRC GI malignancies compared to CRC. Conclusions: Non-CRC GI malignancies demonstrate a distinct BRAF alteration profile compared to CRC, with a higher frequency of class II and III mutations, and more specifically, a higher incidence of BRAF fusions. Future studies should evaluate clinical implications for the management of non-CRC GI patients with BRAF alterations, especially BRAF fusions. Full article
Show Figures

Figure 1

Figure 1
<p>Frequency of <span class="html-italic">BRAF</span> gain-of-function alteration by primary cancer location.</p>
Full article ">Figure 2
<p>Frequency of <span class="html-italic">BRAF</span> gain-of-function alteration type by cancer site in patients with non-colorectal cancer gastrointestinal malignancies.</p>
Full article ">Figure 3
<p>Tissue-based (<b>A</b>) microsatellite instability and (<b>B</b>) tumor mutation burden among patients with <span class="html-italic">BRAF</span> gain-of-function mutation by primary cancer location. Dashed line in figure B represents TMB cut off of 10 mutations/Mb.</p>
Full article ">
16 pages, 1764 KiB  
Article
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors
by Ryan A. Denu, Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour, Anthony P. Conley, Dejka M. Araujo, Vinod Ravi, Elise F. Nassif Haddad, Michael S. Nakazawa, Shreyaskumar Patel, Wei-Lien Wang, Alexander J. Lazar and Neeta Somaiah
Cancers 2024, 16(9), 1707; https://doi.org/10.3390/cancers16091707 - 27 Apr 2024
Cited by 2 | Viewed by 2136
Abstract
Objective: The vast majority of gastrointestinal stromal tumors (GISTs) are driven by activating mutations in KIT, PDGFRA, or components of the succinate dehydrogenase (SDH) complex (SDHA, SDHB, SDHC, and SDHD genes). A small fraction of GISTs lack [...] Read more.
Objective: The vast majority of gastrointestinal stromal tumors (GISTs) are driven by activating mutations in KIT, PDGFRA, or components of the succinate dehydrogenase (SDH) complex (SDHA, SDHB, SDHC, and SDHD genes). A small fraction of GISTs lack alterations in KIT, PDGFRA, and SDH. We aimed to further characterize the clinical and genomic characteristics of these so-called “triple-negative” GISTs. Methods: We extracted clinical and genomic data from patients seen at MD Anderson Cancer Center with a diagnosis of GIST and available clinical next generation sequencing data to identify “triple-negative” patients. Results: Of the 20 patients identified, 11 (55.0%) had gastric, 8 (40.0%) had small intestinal, and 1 (5.0%) had rectal primary sites. In total, 18 patients (90.0%) eventually developed recurrent or metastatic disease, and 8 of these presented with de novo metastatic disease. For the 13 patients with evaluable response to imatinib (e.g., neoadjuvant treatment or for recurrent/metastatic disease), the median PFS with imatinib was 4.4 months (range 0.5–191.8 months). Outcomes varied widely, as some patients rapidly developed progressive disease while others had more indolent disease. Regarding potential genomic drivers, four patients were found to have alterations in the RAS/RAF/MAPK pathway: two with a BRAF V600E mutation and two with NF1 loss-of-function (LOF) mutations (one deletion and one splice site mutation). In addition, we identified two with TP53 LOF mutations, one with NTRK3 fusion (ETV6-NTRK3), one with PTEN deletion, one with FGFR1 gain-of-function (GOF) mutation (K654E), one with CHEK2 LOF mutation (T367fs*), one with Aurora kinase A fusion (AURKA-CSTF1), and one with FANCA deletion. Patients had better responses with molecularly targeted therapies than with imatinib. Conclusions: Triple-negative GISTs comprise a diverse cohort with different driver mutations. Compared to KIT/PDGFRA-mutant GIST, limited benefit was observed with imatinib in triple-negative GIST. In depth molecular profiling can be helpful in identifying driver mutations and guiding therapy. Full article
Show Figures

Figure 1

Figure 1
<p>Clinical characteristics and outcomes in triple-negative GIST. (<b>A</b>) Distribution of age at diagnosis. (<b>B</b>) Distribution of tumor size at diagnosis. (<b>C</b>) Distribution of mitotic count from original biopsy or resected specimen. In (<b>A</b>–<b>C</b>), bars represent means ± SD. (<b>D</b>) Anatomic distribution of triple-negative GIST cases. (<b>E</b>) On the left in colored bars are the initial disease stage. Black and gray bars on the right indicate the percent of patients that remained with localized disease versus those that developed recurrent or metastatic disease. Bars represent percentages plus standard error of proportion.</p>
Full article ">Figure 2
<p>Genomics of triple-negative GIST. (<b>A</b>) Map of the genomic alterations in triple-negative GIST patients. Each row represents a patient. Each column represents a clinical feature (left 3 columns) or gene, as indicated. White boxes indicate that the gene was profiled but that no alteration was found, and gray boxes indicate that the gene was not profiled. (<b>B</b>) Number of somatic mutations detected by clinical sequencing assays. Each dot represents a single tumor, and bars represent mean ± SD. (<b>C</b>) Distribution of the most commonly altered genes in the cohort. (<b>D</b>) Percentage of tumors with each hypothesized driver mutation. In (<b>C</b>,<b>D</b>), percentages plus standard error of proportion are plotted.</p>
Full article ">Figure 3
<p>Response to treatment in triple-negative GIST. (<b>A</b>) Progression-free survival while on imatinib (n = 15 patients) versus molecularly matched treatments (n = 3 patients). <span class="html-italic">p</span> = 0.21. (<b>B</b>) Swimmer’s plot showing timeline of indicated therapies. Purported driver mutation is shown in the column on the left.</p>
Full article ">Figure 4
<p>Survival outcomes in triple-negative GIST. Overall survival (<b>A</b>), recurrence-free survival (<b>B</b>), and progression-free survival (<b>C</b>) of patients with triple- negative GIST. Recurrence-free survival was calculated in patients with initially localized disease from the date of histologic diagnosis to the date of recurrence, death, or the latest follow-up. Progression-free survival was calculated from the start of therapy to the date of recurrence, death, or the latest follow-up.</p>
Full article ">
27 pages, 19690 KiB  
Article
Optimizing Optical Coastal Remote-Sensing Products: Recommendations for Regional Algorithm Calibration
by Rafael Simão, Juliana Távora, Mhd. Suhyb Salama and Elisa Fernandes
Remote Sens. 2024, 16(9), 1497; https://doi.org/10.3390/rs16091497 - 24 Apr 2024
Viewed by 1085
Abstract
The remote sensing of turbidity and suspended particulate matter (SPM) relies on atmospheric corrections and bio-optical algorithms, but there is no one method that has better accuracy than the others for all satellites, bands, study areas, and purposes. Here, we evaluated different combinations [...] Read more.
The remote sensing of turbidity and suspended particulate matter (SPM) relies on atmospheric corrections and bio-optical algorithms, but there is no one method that has better accuracy than the others for all satellites, bands, study areas, and purposes. Here, we evaluated different combinations of satellites (Landsat-8, Sentinel-2, and Sentinel-3), atmospheric corrections (ACOLITE and POLYMER), algorithms (single- and multiband; empirical and semi-analytical), and bands (665 and 865 nm) to estimate turbidity and SPM in Patos Lagoon (Brazil). The region is suitable for a case study of the regionality of remote-sensing algorithms, which we addressed by regionally recalibrating the coefficients of the algorithms using a method for geophysical observation models (GeoCalVal). Additionally, we examined the results associated with the use of different statistical parameters for classifying algorithms and introduced a new metric (GoF) that reflects performance. The best performance was achieved via POLYMER atmospheric correction and the use of single-band algorithms. Regarding SPM, the recalibrated coefficients yielded a better performance, but, for turbidity, a tradeoff between two statistical parameters occurred. Therefore, the uncertainties in the atmospheric corrections and algorithms used were analyzed based on previous studies. In the future, we suggest the use of in situ radiometric data to better evaluate atmospheric corrections, radiative transfer modeling to bridge data gaps, and multisensor data merging for compiling climate records. Full article
(This article belongs to the Section Ocean Remote Sensing)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>(<b>a</b>) Patos Lagoon (South Brazil) with in situ and satellite matchups for turbidity and SPM. Satellites are shown in different colors (orange, blue, and green indicate Sentinel-2 (S2), Sentinel-3 (S3), and Landsat-8 (L8), respectively), while SPM and turbidity matchups are marked with circles and crosses, respectively. The in situ data frequency distributions for (<b>b</b>) SPM and (<b>c</b>) turbidity are split into southern (estuary, in orange) and northern (Guaíba, in blue) areas of the lagoon.</p>
Full article ">Figure 2
<p>Radar plot with the selected statistical parameters (Kendall, MAE, MAPE, and WR). The resultant polygon area (in blue), centroid (red circle), and distance between the radar plot center and polygon centroid (dashed black line) are represented. The goodness of fit (GoF) metric summarizes the algorithm performance and is given by the product of the area and distance.</p>
Full article ">Figure 3
<p>Heatmaps of the turbidity algorithm performance, given in FNU (RMSE, MAE, and bias) or percentage (MAPE and WR) for satellites (<b>a</b>) L8, (<b>b</b>) S2, and (<b>c</b>) S3. The best (worst) performance is shown in green (red).</p>
Full article ">Figure 4
<p>Heatmaps of the SPM algorithm performance, given in g·m<sup>−3</sup> (RMSE, MAE, and bias) or percentage (MAPE and WR) for satellites (<b>a</b>) L8, (<b>b</b>) S2, and (<b>c</b>) S3. The best (worst) performance is shown in green (red).</p>
Full article ">Figure 5
<p>Scatter plots showing the relationships between the measured and estimated turbidity values for satellites (<b>a</b>,<b>d</b>) L8, (<b>b</b>,<b>e</b>) S2, and S3 (<b>c</b>,<b>f</b>), and atmospheric corrections from (<b>a</b>–<b>c</b>) ACOLITE and POLYMER (<b>d</b>–<b>f</b>). For each satellite and atmospheric correction, multiple algorithms (D15 and N09) and bands (665 and 865 nm) are shown.</p>
Full article ">Figure 6
<p>Scatter plots showing the relationships between the measured and estimated SPM concentrations for satellites (<b>a</b>,<b>d</b>) L8, (<b>b</b>,<b>e</b>) S2, and S3 (<b>c</b>,<b>f</b>), and atmospheric corrections from (<b>a</b>–<b>c</b>) ACOLITE and POLYMER (<b>d</b>–<b>f</b>). For each satellite and atmospheric correction, multiple algorithms (N10, N17, and T20) and bands (665 and 865 nm) are shown.</p>
Full article ">Figure 7
<p>Heatmaps of the performance of the turbidity N09 algorithm using original (O) and recalculated (R) coefficients for satellites (<b>a</b>) L8, (<b>b</b>) S2, and (<b>c</b>) S3. The results are given in FNU (RMSE, MAE, and bias) or percentage (MAPE and WR). The best (worst) performance is shown in green (red).</p>
Full article ">Figure 8
<p>Heatmaps of the SPM N10 algorithm performance using the original (O) and recalculated (R) coefficients for satellites (<b>a</b>) L8, (<b>b</b>) S2, and (<b>c</b>) S3. The results are given in g·m<sup>−3</sup> (RMSE, MAE, and bias) or percentage (MAPE and WR). The best (worst) performance is shown in green (red).</p>
Full article ">Figure 9
<p>Scatter plots showing the relationships between the measured and estimated turbidity values for satellites (<b>a</b>,<b>d</b>) L8, (<b>b</b>,<b>e</b>) S2, and (<b>c</b>,<b>f</b>) S3, and atmospheric corrections from (<b>a</b>–<b>c</b>) ACOLITE and (<b>d</b>–<b>f</b>) POLYMER. For each satellite and atmospheric correction, multiple algorithms (N09) and bands (665 and 865 nm) are shown with the original (o) or recalibrated (r) coefficients.</p>
Full article ">Figure 10
<p>Scatter plots showing the relationships between the measured and estimated SPM concentrations for satellites (<b>a</b>,<b>d</b>) L8, (<b>b</b>,<b>e</b>) S2, and (<b>c</b>,<b>f</b>) S3, and atmospheric corrections from (<b>a</b>–<b>c</b>) ACOLITE and (<b>d</b>–<b>f</b>) POLYMER. For each satellite and atmospheric correction, multiple algorithms (N10) and bands (665 and 865 nm) are shown with the original (o) or recalibrated (r) coefficients.</p>
Full article ">Figure 11
<p>Mean SPM concentration in the Patos Lagoon estuary based on S2 scenes, ACOLITE atmospheric correction, the N10 algorithm, the 665 nm band, and (<b>a</b>) original or (<b>b</b>) regionally recalibrated coefficients.</p>
Full article ">Figure 12
<p>(<b>a</b>) Spatial distribution of in situ SPM data, along with the frequency distributions for SPM concentrations measured in situ and satellite-derived using the best combinations for each satellite (L8, S2, and S3) and recalibrated coefficients. The distributions are given for all available data points shown in (<b>a</b>) (including those that are not matchups), divided into three parts of Patos Lagoon: (<b>b</b>) Guaíba, (<b>c</b>) center, and (<b>d</b>) estuary.</p>
Full article ">Figure A1
<p>Time series of the sea surface temperature (SST) of Patos Lagoon based on in situ measurements (SiMCosta buoys) and reanalysis data (SST CCI L4 product).</p>
Full article ">Figure A2
<p>Optical saturation based on the NIR (<span class="html-italic">x</span>-axis) and red (<span class="html-italic">y</span>-axis) reflectance. The red line denotes the fitted regression between these two bands (as in [<a href="#B32-remotesensing-16-01497" class="html-bibr">32</a>]).</p>
Full article ">Figure A3
<p>Radar plots of the statistical parameters for the turbidity estimates. The number after each algorithm and band denotes the area of the associated polygon. The best performance (smaller area) occurs closer to the center.</p>
Full article ">Figure A4
<p>Radar plots of the statistical parameters for the SPM estimates. The number after each algorithm and band denotes the area of the associated polygon. The best performance (smaller area) occurs closer to the center.</p>
Full article ">Figure A5
<p>Radar plots of the statistical parameters for the turbidity estimates using the original (O) and recalibrated (R) coefficients. The number after each algorithm and band denotes the area of the associated polygon. The best performance (smaller area) occurs closer to the center.</p>
Full article ">Figure A6
<p>Radar plots of the statistical parameters for the SPM estimates generated using the original (O) and recalibrated (R) coefficients. The number after each algorithm and band denotes the area of the associated polygon. The best performance (smaller area) occurs closer to the center.</p>
Full article ">
14 pages, 28960 KiB  
Article
HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers
by Nicola Di-Iacovo, Simona Ferracchiato, Stefania Pieroni, Damiano Scopetti, Marilena Castelli, Danilo Piobbico, Luca Pierucci, Marco Gargaro, Davide Chiasserini, Giuseppe Servillo and Maria Agnese Della-Fazia
Int. J. Mol. Sci. 2024, 25(9), 4600; https://doi.org/10.3390/ijms25094600 - 23 Apr 2024
Cited by 1 | Viewed by 1101
Abstract
TP53 mutations are prevalent in various cancers, yet the complexity of apoptotic pathway deregulation suggests the involvement of additional factors. HOPS/TMUB1 is known to extend the half-life of p53 under normal and stress conditions, implying a regulatory function. This study investigates, for the [...] Read more.
TP53 mutations are prevalent in various cancers, yet the complexity of apoptotic pathway deregulation suggests the involvement of additional factors. HOPS/TMUB1 is known to extend the half-life of p53 under normal and stress conditions, implying a regulatory function. This study investigates, for the first time, the potential modulatory role of the ubiquitin-like-protein HOPS/TMUB1 in p53-mutants. A comprehensive analysis of apoptosis in the most frequent p53-mutants, R175, R248, and R273, in SKBR3, MIA PaCa2, and H1975 cells indicates that the overexpression of HOPS induces apoptosis at least equivalent to that caused by DNA damage. Immunoprecipitation assays confirm HOPS binding to p53-mutant forms. The interaction of HOPS/TMUB1 with p53-mutants strengthens its effect on the apoptotic cascade, showing a context-dependent gain or loss of function. Gene expression analysis of the MYC and TP63 genes shows that H1975 exhibit a gain-of-function profile, while SKBR3 promote apoptosis in a TP63-dependent manner. The TCGA data further corroborate HOPS/TMUB1’s positive correlation with apoptotic genes BAX, BBC3, and NOXA1, underscoring its relevance in patient samples. Notably, singular TP53 mutations inadequately explain pathway dysregulation, emphasizing the need to explore additional contributing factors. These findings illuminate the intricate interplay among TP53 mutations, HOPS/TMUB1, and apoptotic pathways, providing valuable insights for targeted cancer interventions. Full article
(This article belongs to the Special Issue Novel Therapeutic Targets in Cancers 2.0)
Show Figures

Figure 1

Figure 1
<p>Analysis of patients from the TCGA pan-cancer dataset reporting missense mutations in the DBD of the <span class="html-italic">TP53</span> gene. (<b>A</b>) Somatic mutation frequency in pan-cancer data. (<b>B</b>) Mutation counts in specific arginine of the DBD of p53 (R175, R213, R248, R273, and R282) in selected cancers. (<b>C</b>) <span class="html-italic">TP53</span> PARADIGM score of patients carrying specific arginine missense mutations in selected cancers. The PARADIGM score is a measure of the activation or inhibition of the most common biological pathways.</p>
Full article ">Figure 2
<p>Apoptosis evaluation of SKBR3, MIA PaCa 2, and H1975 cells, carrying different mutations in p53 DBD. The apoptotic cell percentage (Q2) was evaluated in cells transfected with the control vector pEGFP-N1 (+GFP) or in cells overexpressing HOPS (+ HOPS-GFP). The bar graph shows the apoptotic cell percentage, comparing the control and the HOPS overexpression in each cell line analyzed. The data were analyzed using two-way ANOVA with Holm–Sidak’s multiple comparisons test. The values are represented as percentage mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ns <span class="html-italic">p</span> &gt; 0.05.</p>
Full article ">Figure 3
<p>HOPS binds p53 mutants in SKBR3, MIA PaCa 2, and H1975 after etoposide treatment. GAPDH was used as a normalizer in the whole-cell lysate (WCL).</p>
Full article ">Figure 4
<p>Characterization of apoptosis in SKBR3, MIA PaCa 2, and H1975, after etoposide treatment as a positive control (25 μM etoposide for 4 h) and GFP-tagged HOPS transfection. GAPDH was used as normalizer. The bar graphs are representative of the reported WB and highlight the differences between the total and cleaved caspase 3 (green) and between the total and phosphorylated p53 (red). The HOPS levels are also reported (blue).</p>
Full article ">Figure 5
<p>GOF profile identification of SKBR3, MIA PaCa 2, and H1975 by the gene expression evaluation of MYC and TP63. β-actin was used as a normalizer. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, ns <span class="html-italic">p</span> &gt; 0.05.</p>
Full article ">Figure 6
<p>Analysis of TCGA data showing a strong positive correlation between HOPS/TMUB1 and apoptotic gene BAX, BBC3, and NOXA, in breast invasive carcinoma (<b>A</b>), lung adenocarcinoma (<b>B</b>), and pancreatic adenocarcinoma (<b>C</b>). The boxplot displays the correlations in the HOPS/TMUB1 quartile annotations. The gene expression profile was reported as a transformed RSEM normalized count. The calculation of the correlation levels is shown in <a href="#app1-ijms-25-04600" class="html-app">Figure S2</a>. *** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">
12 pages, 1937 KiB  
Article
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects
by Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam and Jaeseong Oh
Pharmaceuticals 2024, 17(4), 522; https://doi.org/10.3390/ph17040522 - 18 Apr 2024
Viewed by 1367
Abstract
Empagliflozin is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that is commonly used for the treatment of type 2 diabetes mellitus (T2DM). CKD-370 was newly developed as a cocrystal formulation of empagliflozin with co-former L-proline, which has been confirmed to be bioequivalent in South [...] Read more.
Empagliflozin is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that is commonly used for the treatment of type 2 diabetes mellitus (T2DM). CKD-370 was newly developed as a cocrystal formulation of empagliflozin with co-former L-proline, which has been confirmed to be bioequivalent in South Korea. This study aimed to quantify the differences in the absorption phase and pharmacokinetic (PK) parameters of two empagliflozin formulations in healthy subjects by using population PK analysis. The plasma concentration data of empagliflozin were obtained from two randomized, open-label, crossover, phase 1 clinical studies in healthy Korean subjects after a single-dose administration. A population PK model was constructed by using a nonlinear mixed-effects (NLME) approach (Monolix Suite 2021R1). Interindividual variability (IIV) and interoccasion variability (IOV) were investigated. The final model was evaluated by goodness-of-fit (GOF) diagnostic plots, visual predictive checks (VPCs), prediction errors, and bootstrapping. The PK of empagliflozin was adequately described with a two-compartment combined transit compartment model with first-order absorption and elimination. Log-transformed body weight significantly influenced systemic clearance (CL) and the volume of distribution in the peripheral compartment (V2) of empagliflozin. GOF plots, VPCs, prediction errors, and the bootstrapping of the final model suggested that the proposed model was adequate and robust, with good precision at different dose strengths. The cocrystal form did not affect the absorption phase of the drug, and the PK parameters were not affected by the different treatments. Full article
(This article belongs to the Section Pharmacology)
Show Figures

Figure 1

Figure 1
<p>Empagliflozin population PK model. A two-compartment combined transit compartment model with first-order absorption and elimination best fits the observed empagliflozin plasma concentrations. Ktr, transit rate constant; ka, absorption rate constant; Q, intercompartmental clearance; CL, clearance.</p>
Full article ">Figure 2
<p>Goodness-of-fit plots of the final population pharmacokinetic model for empagliflozin. (<b>A</b>) Population predicted concentrations (PRED) against observed plasma concentration; (<b>B</b>) individual-predicted concentrations (IPRED) against observed plasma concentration; (<b>C</b>) time against conditional weighted residuals; (<b>D</b>) PRED against conditional weighted residuals. Red dots mean the data are not censored.</p>
Full article ">Figure 3
<p>Normalized prediction distribution error (NPDE) metrics for the population pharmacokinetic model of empagliflozin. Normal Q–Q plot for NPDE (<b>A</b>), distribution of NPDE (<b>B</b>), and NPDE versus time after the first dose (<b>C</b>) and versus predicted concentrations (<b>D</b>). Red dots mean the data are not censored.</p>
Full article ">Figure 4
<p>Linear scale (<b>A</b>) and semi-log scale (<b>B</b>) of visual predictive checks (VPCs) (500 simulations) of the final model for empagliflozin. The observed concentrations are depicted by dots. The solid blue lines indicate the 95th, 50th, and 5th percentiles of the observed concentrations. The black dashed lines indicate the predicted means. The blue shaded regions indicate the 95% confidence intervals for the predicted 5th and 95th percentiles. Pink shaded regions indicate the 95% confidence intervals for the predicted 50th percentiles. The red dots indicate the conserved data, and the red shaded regions indicate the outlined areas.</p>
Full article ">
22 pages, 1331 KiB  
Article
Assessing System Quality Changes during Software Evolution: The Impact of Design Patterns Explored via Dependency Analysis
by Kuo-Hsun Hsu, Hua-Chieh Szu-Tu and Chia-Hsing Tsai
Electronics 2024, 13(8), 1444; https://doi.org/10.3390/electronics13081444 - 11 Apr 2024
Viewed by 806
Abstract
Design patterns provide solutions to recurring problems in software design and development, promoting scalability, readability, and maintainability. While past research focused on the utilization of the design patterns and performance, there is limited insight into their impact on program evolution. Dependency signifies relationships [...] Read more.
Design patterns provide solutions to recurring problems in software design and development, promoting scalability, readability, and maintainability. While past research focused on the utilization of the design patterns and performance, there is limited insight into their impact on program evolution. Dependency signifies relationships between program elements, reflecting a program’s structure and interaction. High dependencies indicate complexity and potential flaws, hampering system quality and maintenance. This paper presents how design patterns influence software evolution by analyzing dependencies using the Abstract Syntax Tree (AST) to examine dependency patterns during evolution. We employed three widely adopted design patterns from the Gang of Four (GoF) as experimental examples. The results show that design patterns effectively reduce dependencies, lowering system complexity and enhancing quality. Full article
(This article belongs to the Special Issue Advances in Software Engineering and Programming Languages)
Show Figures

Figure 1

Figure 1
<p>Categorization of dependency relationships.</p>
Full article ">Figure 2
<p>System architecture.</p>
Full article ">Figure 3
<p>Experimental steps.</p>
Full article ">Figure 4
<p>Decorator program design.</p>
Full article ">Figure 5
<p>Factory program design.</p>
Full article ">Figure 6
<p>Factory Pattern: total encapsulation dependencies.</p>
Full article ">Figure 7
<p>Factory Pattern: avg. encapsulation dependencies per class.</p>
Full article ">Figure 8
<p>Factory Pattern: total abstraction dependencies.</p>
Full article ">Figure 9
<p>Factory Pattern: avg. abstraction dependencies per class.</p>
Full article ">Figure 10
<p>Factory Pattern: total delegation dependencies.</p>
Full article ">Figure 11
<p>Factory Pattern: avg. delegation dependencies per class.</p>
Full article ">Figure 12
<p>Decorator Pattern: total encapsulation dependencies.</p>
Full article ">Figure 13
<p>Decorator Pattern: avg. encapsulation dependencies per class.</p>
Full article ">Figure 14
<p>Decorator Pattern: total abstraction dependencies.</p>
Full article ">Figure 15
<p>Decorator Pattern: avg. abstraction dependencies per class.</p>
Full article ">Figure 16
<p>Decorator Pattern: total delegation dependencies.</p>
Full article ">Figure 17
<p>Decorator Pattern: avg. delegation dependencies per class.</p>
Full article ">Figure 18
<p>Observer program design.</p>
Full article ">Figure 19
<p>Observer Pattern: total encapsulation dependencies.</p>
Full article ">Figure 20
<p>Observer Pattern: avg. encapsulation dependencies per class.</p>
Full article ">Figure 21
<p>Observer Pattern: total abstraction dependencies.</p>
Full article ">Figure 22
<p>Observer Pattern: avg. abstraction dependencies per class.</p>
Full article ">Figure 23
<p>Observer Pattern: total delegation dependencies.</p>
Full article ">Figure 24
<p>Observer Pattern: avg. delegation dependencies per class.</p>
Full article ">
17 pages, 325 KiB  
Review
Infections in Disorders of Immune Regulation
by Abarna Thangaraj, Reva Tyagi, Deepti Suri and Sudhir Gupta
Pathogens 2024, 13(3), 259; https://doi.org/10.3390/pathogens13030259 - 17 Mar 2024
Viewed by 2193
Abstract
Primary immune regulatory disorders (PIRDs) constitute a spectrum of inborn errors of immunity (IEIs) that are primarily characterized by autoimmunity, lymphoproliferation, atopy, and malignancy. In PIRDs, infections are infrequent compared to other IEIs. While susceptibility to infection primarily stems from antibody deficiency, it [...] Read more.
Primary immune regulatory disorders (PIRDs) constitute a spectrum of inborn errors of immunity (IEIs) that are primarily characterized by autoimmunity, lymphoproliferation, atopy, and malignancy. In PIRDs, infections are infrequent compared to other IEIs. While susceptibility to infection primarily stems from antibody deficiency, it is sometimes associated with additional innate immune and T or NK cell defects. The use of immunotherapy and chemotherapy further complicates the immune landscape, increasing the risk of diverse infections. Recurrent sinopulmonary infections, particularly bacterial infections such as those associated with staphylococcal and streptococcal organisms, are the most reported infectious manifestations. Predisposition to viral infections, especially Epstein–Barr virus (EBV)-inducing lymphoproliferation and malignancy, is also seen. Notably, mycobacterial and invasive fungal infections are rarely documented in these disorders. Knowledge about the spectrum of infections in these disorders would prevent diagnostic delays and prevent organ damage. This review delves into the infection profile specific to autoimmune lymphoproliferative syndrome (ALPS), Tregopathies, and syndromes with autoimmunity within the broader context of PIRD. Despite the critical importance of understanding the infectious aspects of these disorders, there remains a scarcity of comprehensive reports on this subject. Full article
(This article belongs to the Special Issue Infection in Inborn Errors of Immunity)
13 pages, 1298 KiB  
Review
Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency
by Clifford Liongue, Tarindhi Ratnayake, Faiza Basheer and Alister C. Ward
Int. J. Mol. Sci. 2024, 25(5), 2977; https://doi.org/10.3390/ijms25052977 - 4 Mar 2024
Cited by 1 | Viewed by 1696
Abstract
The Janus kinase (JAK) family is a small group of protein tyrosine kinases that represent a central component of intracellular signaling downstream from a myriad of cytokine receptors. The JAK3 family member performs a particularly important role in facilitating signal transduction for a [...] Read more.
The Janus kinase (JAK) family is a small group of protein tyrosine kinases that represent a central component of intracellular signaling downstream from a myriad of cytokine receptors. The JAK3 family member performs a particularly important role in facilitating signal transduction for a key set of cytokine receptors that are essential for immune cell development and function. Mutations that impact JAK3 activity have been identified in a number of human diseases, including somatic gain-of-function (GOF) mutations associated with immune cell malignancies and germline loss-of-function (LOF) mutations associated with immunodeficiency. The structure, function and impacts of both GOF and LOF mutations of JAK3 are highly conserved, making animal models highly informative. This review details the biology of JAK3 and the impact of its perturbation in immune cell-related diseases, including relevant animal studies. Full article
(This article belongs to the Section Molecular Immunology)
Show Figures

Figure 1

Figure 1
<p>Structure and function of the JAK proteins. (<b>A</b>) Diagram of a JAK protein showing the four domains common in all family members: FERM (yellow), SH2 (pink), pseudo-PTK (fawn) and PTK (orange). (<b>B</b>) Schematic representation of major cytokine receptor signaling pathways, highlighting the key role for JAK proteins. Various cytokines (Cyto) bind to their specific cytokine receptor complex (CytoR) to activate associated JAK proteins that mediate extensive tyrosine phosphorylation that initiates multiple intracellular signaling pathways to facilitate a variety of cellular impacts. Abbreviations: AKT: Ak strain transforming; CSF: colony-stimulating factor; ERK: extracellular-regulated kinase; FERM: four-point-one, ezrin, radixin, moesin; IFN: interferon; IL: interleukin; PI3K: phosphatidyl inositol 3′-kinase; PTK: protein tyrosine kinase; RAS: rat sarcoma; SH2: SRC homology 2; STAT: signal transducer and activator of transcription.</p>
Full article ">Figure 2
<p>Central role for JAK3 in signaling via the interleukin 2 cytokine receptor family. Schematic representation of the cytokine receptor signaling complexes for the interleukin 2 (IL-2) family of cytokines (gray ellipses), including IL-2 (green edge), IL-4 (brown edge), IL-7 (orange edge), IL-9 (purple edge), IL-15 (red edge) and IL-21 (pink edge), with their respective ligand-specific chains (green, matching edges), the shared IL-2 receptor gamma common (IL-2Rγc) signaling chain (light blue), with an additional shared IL-2 receptor beta (IL-2Rβ) chain (dark blue) in two cases. Associated with the IL-2Rγc chain is JAK3 (blue edge) and associated with one of the alternative chains is JAK1 (brown edge). These cytokine receptor complexes activate multiple signaling pathways but particularly the indicated STAT proteins, STAT3 (brown), STAT5 (green) and STAT6 (blue). Below this is indicated the major cell lineage impacted by each cytokine receptor signaling complex. Abbreviations: IL: interleukin; NK: natural killer; Tfh: follicular helper T cell; Th: helper T cell; Tmem: memory T cell; Treg: regulatory T cell.</p>
Full article ">Figure 3
<p>JAK3 mutations associated with immune cell diseases. Schematic of the JAK3 protein and its constituent FERM (yellow), SH2 (pink), pseudo-PTK (fawn), and PTK (orange) domains, showing representative gain-of-function mutations (purple, above), typically mono-allelic and somatic, associated with immune cell cancers, and loss-of-function (red, below) mutations, typically bi-allelic and germline, associated with immunodeficiency [<a href="#B45-ijms-25-02977" class="html-bibr">45</a>,<a href="#B46-ijms-25-02977" class="html-bibr">46</a>,<a href="#B47-ijms-25-02977" class="html-bibr">47</a>,<a href="#B48-ijms-25-02977" class="html-bibr">48</a>,<a href="#B49-ijms-25-02977" class="html-bibr">49</a>,<a href="#B50-ijms-25-02977" class="html-bibr">50</a>,<a href="#B51-ijms-25-02977" class="html-bibr">51</a>,<a href="#B52-ijms-25-02977" class="html-bibr">52</a>,<a href="#B53-ijms-25-02977" class="html-bibr">53</a>,<a href="#B54-ijms-25-02977" class="html-bibr">54</a>,<a href="#B55-ijms-25-02977" class="html-bibr">55</a>,<a href="#B56-ijms-25-02977" class="html-bibr">56</a>,<a href="#B57-ijms-25-02977" class="html-bibr">57</a>,<a href="#B58-ijms-25-02977" class="html-bibr">58</a>].</p>
Full article ">
14 pages, 324 KiB  
Article
A New Test Statistic to Assess the Goodness of Fit of Location-Scale Distribution Based on Progressive Censored Data
by Kyeongjun Lee
Symmetry 2024, 16(2), 202; https://doi.org/10.3390/sym16020202 - 8 Feb 2024
Cited by 1 | Viewed by 1157
Abstract
The problem of examining how well the data fit a supposed distribution is very important, and it must be confirmed prior to any data analysis, because many data analysis methods assume a specific distribution of data. For this purpose, histograms or Q-Q plots [...] Read more.
The problem of examining how well the data fit a supposed distribution is very important, and it must be confirmed prior to any data analysis, because many data analysis methods assume a specific distribution of data. For this purpose, histograms or Q-Q plots are employed for the assessment of data distribution. Additionally, a GoF TstS utilizes distance measurements between the empirical distribution function and the theoretical cumulative distribution function (cdf) to evaluate data distribution. In life-testing or reliability studies, the observed failure time of test units may not be recorded in some situations. The GoF TstSs for completely observed data can no longer be used in progressive type II censored data (PrCsD). In this paper, we suggest a GoF TstSs and new plot method for the GoF test of symmetric and asymmetric location-scale distribution (LoScD) based on PrCsD. The power of the suggested TstSs is estimated through Monte Carlo (MC) simulations, and it is compared with that of the TstSs using the order statistics (OrSt). Furthermore, we analyzed real data examples (symmetric and asymmetric data). Full article
Show Figures

Figure 1

Figure 1
<p>Sample LrCv and modified sample LrCv of GumDist and LGamDist.</p>
Full article ">Figure 2
<p>Sample LrCv and modified sample LrCv of NormDist and <span class="html-italic">t</span>Dist.</p>
Full article ">Figure 3
<p><math display="inline"><semantics> <mrow> <mi>L</mi> <mo>−</mo> <mi>p</mi> <mi>l</mi> <mi>o</mi> <mi>t</mi> <mo>(</mo> <msub> <mi>p</mi> <mrow> <mi>j</mi> <mo>:</mo> <mi>m</mi> <mo>:</mo> <mi>n</mi> </mrow> </msub> <mo>)</mo> </mrow> </semantics></math> of various LoScDs.</p>
Full article ">Figure 4
<p><math display="inline"><semantics> <mrow> <mi>L</mi> <mo>−</mo> <mi>p</mi> <mi>l</mi> <mi>o</mi> <mi>t</mi> <mo>(</mo> <msub> <mi>p</mi> <mrow> <mi>j</mi> <mo>:</mo> <mi>m</mi> <mo>:</mo> <mi>n</mi> </mrow> </msub> <mo>)</mo> </mrow> </semantics></math> of examples.</p>
Full article ">
24 pages, 8154 KiB  
Article
GNSS Radio Frequency Interference Monitoring from LEO Satellites: An In-Laboratory Prototype
by Micaela Troglia Gamba, Brendan David Polidori, Alex Minetto, Fabio Dovis, Emilio Banfi and Fabrizio Dominici
Sensors 2024, 24(2), 508; https://doi.org/10.3390/s24020508 - 13 Jan 2024
Cited by 2 | Viewed by 2268
Abstract
The disruptive effect of radio frequency interference (RFI) on global navigation satellite system (GNSS) signals is well known, and in the last four decades, many have been investigated as countermeasures. Recently, low-Earth orbit (LEO) satellites have been looked at as a good opportunity [...] Read more.
The disruptive effect of radio frequency interference (RFI) on global navigation satellite system (GNSS) signals is well known, and in the last four decades, many have been investigated as countermeasures. Recently, low-Earth orbit (LEO) satellites have been looked at as a good opportunity for GNSS RFI monitoring, and the last five years have seen the proliferation of many commercial and academic initiatives. In this context, this paper proposes a new spaceborne system to detect, classify, and localize terrestrial GNSS RFI signals, particularly jamming and spoofing, for civil use. This paper presents the implementation of the RFI detection software module to be hosted on a nanosatellite. The whole development work is described, including the selection of both the target platform and the algorithms, the implementation, the detection performance evaluation, and the computational load analysis. Two are the implemented RFI detectors: the chi-square goodness-of-fit (GoF) algorithm for non-GNSS-like interference, e.g., chirp jamming, and the snapshot acquisition for GNSS-like interference, e.g., spoofing. Preliminary testing results in the presence of jamming and spoofing signals reveal promising detection capability in terms of sensitivity and highlight room to optimize the computational load, particularly for the snapshot-acquisition-based RFI detector. Full article
Show Figures

Figure 1

Figure 1
<p>GNSS RFI monitoring system operational scenario (not to scale).</p>
Full article ">Figure 2
<p>Block diagram of the FFT-based parallel code-phase search algorithm used as GNSS-like RFI detector. The <math display="inline"><semantics> <mrow> <mfenced separators="|"> <mrow> <mo>·</mo> </mrow> </mfenced> <mtext> </mtext> </mrow> </semantics></math>operator indicates the complex conjugate.</p>
Full article ">Figure 3
<p>Block diagram of the GNSS RFI detection breadboard to be hosted on-board a LEO satellite.</p>
Full article ">Figure 4
<p>Test setup for the jamming detection evaluation.</p>
Full article ">Figure 5
<p>GoF-based RFI detector results for the sensitivity test: jamming power varying from −102.2 dBm to −92.2 dBm (<b>a</b>), −92.2 dBm to −82.2 dBm (<b>b</b>), −82.2 dBm to −72.2 dBm (<b>c</b>), −72.2 dBm to −62.2 dBm (<b>d</b>), −62.2 dBm to −52.2 dBm (<b>e</b>), and −52.2 dBm to −42.2 dBm (<b>f</b>).</p>
Full article ">Figure 6
<p>Histogram of the raw samples collected during the sensitivity test for two jamming power levels, i.e., −102.2 dBm and −92.2 dBm, and the reference histogram.</p>
Full article ">Figure 7
<p>GoF-based RFI detector results for the OFF-ON test: the jammer is switched on around 29 s with −42.2 dBm power.</p>
Full article ">Figure 8
<p>Test setup for the spoofing detection evaluation.</p>
Full article ">Figure 9
<p>Power and Doppler profiles of the generated spoofing signals.</p>
Full article ">Figure 10
<p>Detection rate of the GPS 4 (<b>a</b>) and Galileo 24 (<b>b</b>) as a function of the carrier-to-noise ratio, obtained respectively with the sets of parameters S1–S5 (different values of non-coherent sums <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>N</mi> </mrow> <mrow> <mi>n</mi> <mi>c</mi> </mrow> </msub> </mrow> </semantics></math>) and sets of parameters S6–S9 (different values of non-coherent sums <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>N</mi> </mrow> <mrow> <mi>n</mi> <mi>c</mi> </mrow> </msub> </mrow> </semantics></math> and Doppler step <math display="inline"><semantics> <mrow> <msub> <mrow> <mo>∆</mo> </mrow> <mrow> <mi>d</mi> </mrow> </msub> </mrow> </semantics></math>) in <a href="#sensors-24-00508-t003" class="html-table">Table 3</a>.</p>
Full article ">Figure 11
<p>Comparison of the GPS L1 and Galileo E1B detection rate for the same number of non-coherent sums <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>N</mi> </mrow> <mrow> <mi>n</mi> <mi>c</mi> </mrow> </msub> <mo>=</mo> <mn>8</mn> </mrow> </semantics></math>, and LEO’s compatible Doppler profile as in <a href="#sensors-24-00508-f009" class="html-fig">Figure 9</a> (<b>a</b>) and close-to-zero constant Doppler (<b>b</b>). In (<b>b</b>), the GNSS input signal has been generated with NFUELS [<a href="#B74-sensors-24-00508" class="html-bibr">74</a>] with constant Doppler equal to 50 Hz for both GPS and Galileo satellites.</p>
Full article ">Figure 12
<p>GPS L1 (<b>a</b>) and Galileo E1B (<b>b</b>) snapshot acquisition results, obtained with the sets of parameters S1 in <a href="#sensors-24-00508-t003" class="html-table">Table 3</a> and <a href="#sensors-24-00508-t004" class="html-table">Table 4</a>, respectively, for the OFF-ON test: The spoofer is switched on around 27 s with −130 dBm power.</p>
Full article ">
Back to TopTop